Michigan-based HistoSonics is about $51,000 shy of closing a $14.2 million funding round in support of its non-invasive tissue ablation technology.
Michigan medical device maker HistoSonics is creeping toward the close of a $14.22 million funding round in support of its non-invasive tissue ablation technology.
The company has raised about $14.17 million so far from 13 unnamed investors, through sales of equity, options, warrants and other rights to acquire securities, according to an SEC filing dated May 16.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1vzlUtA
Cap comentari:
Publica un comentari a l'entrada